Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES); Scale-Up

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA). View current information on nida.nih.gov.

This study will build on lessons learned from the CHOICES pilot study (CTN-0055) and to advance understanding of XR-NTX adoption in HIV primary care settings.  HIV primary care clinics are being selected to participate in an open-label trial of office-based XR-NTX in HIV-infected participants with untreated opioid use disorder or alcohol use disorders.  

CTN Protocol ID: 
CTN-0067

Principal Investigator(s)

Todd Korthuis, M.D., M.P.H.
Associate Professor of Medicine
Oregon Health & Science University
Department of Public Health & Preventive Medicine
3181 Southwest Sam Jackson Park Road, L475
Portland, OR 97239-3098
United States
korthuis@ohsu.edu